KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa

R. Jain, V. V. Beckett, M. W. Konstan, F. J. Accurso, J. L. Burns, N. Mayer-Hamblett, Carlos Milla, D. R. VanDevanter, J. F. Chmiel

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint Dive into the research topics of 'KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa'. Together they form a unique fingerprint.

Medicine & Life Sciences